Buscar
Congreso SOLACI
InicioStructural heart diseaseOther

Other

Ver Categoría

Other

ESC 2020 | New Drug Improves Functional Capacity in Hypertrophic Cardiomyopathy

In patients with hypertrophic cardiomyopathy, myosin inhibitor mavacamten plus optimal medical therapy improved hemodynamics, functional capacity, and...
solaci -
Ver más
Congenital cardiopathy

Procedural Rescheduling Criteria in the Pandemic Era

Patients with structural heart disease are at higher risk in the face of the new coronavirus infection...
solaci -
Ver más
Antithrombotic Anticoagulants

Net Benefit of Left Atrial Appendage Closure vs. Anticoagulation in Atrial Fibrillation

This analysis shows that the long-term clinical benefit of left atrial appendage closure with Watchman is superior...
solaci -
Ver más
Other

5-Year Experience of Appendage Closure: More Evidence that Does Not Translate into Clinical Practice

The use of percutaneous left appendage closure increased 3.6-fold from 2011 to 2015, but this volume increase...
solaci -
Ver más
Other

Long-Term Foramen Ovale Closure after Cryptogenic Stroke

Patent foramen ovale closure is the standard treatment for cryptogenic stroke patients. However, there are is little...
solaci -
Ver más
Other

ACC 2019 | POET: Oral Antibiotics with Good Long-Term Results for Endocarditis

This work found better survival rates with oral treatment, an outcome that may be credited to shorter...
solaci -
Ver más
Other

Contemporary Results for Septal Embolization in Hypertrophic Cardiomyopathy

This work showed that percutaneous septal ablation in patients with symptomatic hypertrophic cardiomyopathy is safe (and improves...
solaci -
Ver más
Other

AHA 2018 | Endocarditis Prophylaxis More Limited after AHA 2007 Guidelines

The incidence of infective endocarditis had decreased after AHA 2007 recommendations. At present, some patients are not...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Selecting Renal Denervation Responsive Patients: Meta-Analysis of Observational Data

solaci - 0
Hypertension treatment has evolved considerably over time. However, managing adverse events driven by medication is still challenging, as is low patient adherence, be it...

Myocardial Damage in MAC

solaci - 0
Mitral annulus calcification (MAC) affects between 8% and 23% of the population. It is more common in women and patients with renal insufficiency. This...

Initial Complete Revascularization vs. Staged Revascularization in Patients with STEMI and Multivessel Disease

solaci - 0
In patients with ST-segment elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (primary PCI), multivessel disease is observed in up to 40%...

Noticias Institucionales

National and Internacional Live Cases at the Next SOLACI-CACI 2024

solaci - 0
Discover all the live national and international cases at the upcoming SOLACI-CACI 2024 Congress. Scientific program Register now con descuentos   Live International Transmission Tribute to Alain Cribier...

Discover the international guests of the SOLACI-CACI 2024 Congress

solaci - 0
We are getting closer to the largest gathering of interventional cardiologists in Latin America. Discover the prestigious guests from Europe, Asia, and the United...

New Issue of SOLACI-LATAM Peripheral Registry in the European Medical Journal

solaci - 0
We are proud to announce that the Latin American Society of Interventional Cardiology is sharing their latest issue of SOLACI-LATAM Peripheral Registry in the...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad